Internal Medicine, Pulmonary Disease · Elkton, MD
NPI
1396703351
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
4
Hospital affiliations
216 E Pulaski Hwy, Suite 235
Elkton, MD, 21921
Phone (410) 620-1984
Groups this clinician bills Medicare through
Medicare paid, 2024
$414K
5,345 services
Medicare patients, 2024
1,187
Average age 72
Drug cost, 2024
$3.1M
5,248 prescriptions
Company payments, 2025
$2,953
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua N Aaron was code 99215 (office e&m - established), 1,703 times for 949 patients. In total Joshua N Aaron billed 5,345 services in 25 codes, and Medicare paid $414K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,703 | 949 | $132.01 | $225K |
| 94726 Pulmonary Function Testing | Office | 405 | 404 | $41.77 | $17K |
| 94060 Pulmonary Function Testing | Office | 405 | 404 | $29.95 | $12K |
| 94729 Pulmonary Function Testing | Office | 405 | 404 | $42.93 | $17K |
| 94200 Pulmonary Function Testing | Office | 403 | 402 | $11.63 | $4,685 |
| 94664 E&M - Miscellaneous | Office | 402 | 401 | $14.03 | $5,640 |
| 94010 Pulmonary Function Testing | Office | 371 | 302 | $20.52 | $7,612 |
| 99454 E&M - Miscellaneous | Office | 291 | 35 | $36.05 | $10K |
| 99457 E&M - Miscellaneous | Office | 200 | 33 | $37.42 | $7,485 |
| 94618 Pulmonary Function Testing | Office | 129 | 124 | $26.06 | $3,362 |
| 99205 Office E&M - New | Office | 119 | 119 | $165.39 | $20K |
| 99214 Office E&M - Established | Office | 104 | 61 | $81.31 | $8,457 |
| 99204 Office E&M - New | Office | 90 | 90 | $119.95 | $11K |
| 95810 Sleep Study | Office | 74 | 72 | $373.21 | $28K |
| 95811 Sleep Study | Office | 67 | 64 | $410.29 | $27K |
By year: 2022 $455K for 6,283 services; 2023 $447K for 6,276 services; 2024 $414K for 5,345 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua N Aaron prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 830 prescriptions and refills. In total Joshua N Aaron wrote 5,248 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 830 | 1,021 | 295 | $28K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 590 | 846 | 142 | $525K |
| Montelukast Sodium Generic | 413 | 1,080 | 137 | $8,442 |
| Fluticasone Propionate Generic | 208 | 371 | 81 | $3,569 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 208 | 276 | 54 | $170K |
| Spiriva Respimat Tiotropium Bromide | 207 | 258 | 45 | $132K |
| Ventolin Hfa Albuterol Sulfate | 159 | 204 | 72 | $14K |
| Breo Ellipta Fluticasone/Vilanterol | 147 | 209 | 36 | $80K |
| Prednisone Generic | 138 | 201 | 71 | $771 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 130 | 207 | 46 | $19K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 112 | 137 | 22 | $61K |
| Roflumilast Generic | 108 | 192 | 27 | $13K |
| Incruse Ellipta Umeclidinium Bromide | 105 | 137 | 28 | $45K |
| Azelastine Hcl Generic | 90 | 147 | 35 | $2,756 |
| Symbicort Budesonide/Formoterol Fumarate | 90 | 130 | 29 | $29K |
Brand drugs: 2,907 claims; generic drugs: 2,341 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua N Aaron $2,953 ($2,953 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $725.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $725 |
| Mallinckrodt Hospital Products Inc. | 10 | $330 |
| Axsome Therapeutics, Inc. AXSM | 12 | $266 |
| Jazz Pharmaceuticals Inc. JAZZ | 8 | $258 |
| Verona Pharma, Inc. VRNA | 14 | $225 |
| Pulmonx Corporation LUNG | 7 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $161 |
| GlaxoSmithKline, LLC. GSK | 9 | $157 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $102 |
| Grifols USA, LLC | 5 | $89.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.